A Follow-Up Study of Multibacillary Hansen's Disease Patients Treated with Multidrug Therapy (MDT) or MDT + Immunotherapy (IMT)

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 65, Issue 3, 1997, Pages 320-327

  Rada, Elsa ^a   Ulrich, Marian ^a   Aranzazu, Nacarid ^a   Rodriguez, Vestalia ^a   Centeno, Marta ^a   Gonzalez, Ivonne ^a   Santaella, Carlos ^a   Rodriguez, Morella ^a   Convit, Jacinto ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CLOFAZIMINE; DAPSONE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MYCOBACTERIUM ANTIGEN; NITRITE; RIFAMPICIN;

ARTICLE; CLINICAL PROTOCOL; FEMALE; HUMAN; IMMUNOTHERAPY; INTRATHECAL DRUG ADMINISTRATION; LEPROSY; LYMPHOCYTE TRANSFORMATION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM LEPRAE; RELAPSE; TREATMENT OUTCOME;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLYCOLIPIDS; HUMANS; LEPROSTATIC AGENTS; LEPROSY; LYMPHOCYTE ACTIVATION; MALE; MYCOBACTERIUM LEPRAE; NITRITES; VACCINATION; VACCINES, INACTIVATED;

EID: 0030657543     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. ARANZAZU, N. and ACOSTA, L. Enfermedad de Hansen, In: Dermatologia Rondón Lugo. Godoy, R., ed. Caracas: Industria Editorial Venezolana, 1995, pp. 557-569.
2. BACH, M. A., WALLACH, D., FLAGEUL, B., HOFFENBACH, A. and COTTENOT, F. Antibodies to phenolic glycolipid-I and to whole Mycobacterium leprae in leprosy patients: evolution during therapy. Int. J. Lep. 54 (1986) 256-267.
3. BOYUM, A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21 (1968) 77-89.
4. BRENNAN, P. J. and BARROW, W. W. Evidence for species-specific lipid antigens in M. leprae. Int. J. Lepr. 48 (1980) 382-387.
5. BUSTER, B. L., WETROB, A. C., TOWNSEND, G. C. and SCHELD, W. M. Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect. Immun. 63 (1995) 3835-3839.
6. CHANTEAU, S., CARTEL, I. L., CELERIER, P., PLICHART, R., DESFORGES, S. and Roux, J. PGL-I antigen and antibodies detection in leprosy patients: evolution under chemotherapy. Int. J. Lepr. 57 (1989) 735-743.
7. CONVIT, J., ULRICH, M., ARANZAZU, N., CASTELLANOS, P. L., PINARDI, M. E. and REYES, O. The development of a vaccination model using two microorganisms and its applications in leprosy and leishmaniasis. Lepr. Rev. 57 (1986) 263-273.
8. GREEN, L. C., WAGNER, D. A., GLOGOWSKI, J., SKIPPER, P. L., WISHNOK, J. S. and TANNENBAUM, S. R. Analysis of nitrate, nitrite and (15 N) nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138.
9. HIBBS, J. B., JR., TAINDOR, R. and VAVRIN, Z. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157 (1988) 87-94.
10. JI, B. and GROSSET, J. H. Recent advances in the chemotherapy of leprosy. Lepr. Rev. 61 (1990) 313-329.
11. KNOWLES, R. G., PALACIOS, R., PALMER, M. J. and MONCADA, S. Formation of nitric oxide from Larginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase, Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5159-5162.
12. MAJUMDER, V., MUKERJEE, A., HAJRA, S. K., SAHA, B. and SAHA, K. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose Convit vaccine along with multidrug therapy (Calcutta trial). Int. J. Lepr. 64 (1996) 26-36.
13. MEEKER, H. C., SHULLER-LEVIS, G., Fusco, F., GiARDINA-BECKET, M., SERSEN, E. and LEVIS, W. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I and mycobacterial lipoarabinomannan. Int. J. Lepr. 58 (1990) 503-511.
14. MUSTAFA, A. S. and OFTUNG, F. Long lasting T cell reactivity to Mycobacterium leprae antigens in human volunteers vaccinated with killed M. leprae. Vaccine 11 (1993) 1108-1112.
15. RADA, E., SANTAELLA, C., ARANZAZU, N. and CONVIT, J. Preliminary study of cellular immunity to Mycobacterium leprae protein in contacts and leprosy patients. Int. J. Lepr. 60 (1992) 189-194.
16. RADA, E., ULRICH, M., ARANZAZU, N., SANTAELLA, C., GALLINOTO, M. E., CENTENO, M., RODRIGUEZ, V. and CONVIT, J. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Int. J. Lepr. 62 (1994) 552-558.
17. RIDLEY, D. S. and JOPLING, W. H. Classification of leprosy according to immunity; a five-group system system. Int. J. Lepr. 34 (1966) 255-273.
18. SHARPLES, C. E., SHAW, M., CASTES, M., CONVIT, J. and BLACKWELL, J. Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes antibody responses to mycobacterial and leishmanial antigens. Vaccine 12 (1994) 1402-1412.
19. SHIRAISHI, T., DEMEESTER, S. R., WORRALL, N. K., RITTER, J. H., MISKO, T. P., FERGUNSON, T. B., JR., COOPER, J. D. and PATTERSON, G. A. Inhibition of inducible nitric oxide synthetase ameliorates rat lung allograft rejection. J. Thorac. Cardiovasc. Surg. 110 (1995) 1449-1459.
20. THAI, S. F, LEWIS, J. B., WILLIAMS, R. B., JOHNSON, S. P. and ADAMS D. O. Effect of oxidized LDL on mononuclear phagocytes: inhibition of induction of four inflammatory cytokine gene RNAs, release of NO, and cytolysis of tumor cells. Leukoc. Biol. 57 (1995) 427-433.
21. ULRICH, M., SMITH, P. G., SAMPSON, C., ZUNIGA, M., CENTENO, M., GARCIA, V., MANRIQUE, X., SALGADO, A. and CONVIT, J. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and prospective study of the risk of leprosy. Int. J. Lepr. 59 (1991) 405-415.
22. E (RII/CD23) surface antigens. Proc. Natl. Acad. Sci U.S.A. 92 (1995) 7804-7808.
23. WATERS, M. F. R. Chemotherapy of leprosy - current status and future prospects. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 500-503.
24. WHO EXPERT COMMITTEE ON LEPROSY. Sixth report. Geneva: World Health Organization, 1988. Tech. Rep. Ser. 768
25. YOUNG, D. B. and BUCHANAN, T. H. A serological test for leprosy with a glycolipid specific for M. leprae. Science 221 (1983) 1057-1059.